Chapter 51: Immunizing Drugs & Pandemic Preparedness

The text establishes the two primary types of immunity: active immunization, where a host is exposed to a harmless form of an antigen (via vaccines or toxoids) to stimulate the long-lasting production of its own antibodies and immunological memory through the humoral immune system; and passive immunization, which involves directly administering preformed antibodies (immunoglobulins, antitoxins, or antivenins) to provide rapid, temporary protection, thereby bypassing the host's immune response. Essential active immunizing drugs covered include multi-component vaccines for diphtheria, tetanus, and pertussis (DTaP/Tdap), as well as specific preparations against Hepatitis B, Influenza (which requires annual updates due to circulating strains), Measles, Mumps, Rubella (MMR), Poliovirus, Pneumococcal disease, and the Human Papillomavirus (HPV), which uniquely prevents associated cancers. Nursing considerations are crucial and encompass detailed patient assessment for potential contraindications—such as severe febrile illness, pregnancy, or immunocompromised status, especially when live attenuated vaccines are involved—along with strict adherence to Canadian immunization schedules recommended by the National Advisory Committee on Immunization (NACI). Furthermore, the chapter addresses the critical role of nurses in pandemic preparedness, discussing Canada's planning framework (CPIP) designed to minimize illness, death, and societal disruption, while also tackling issues like vaccine hesitancy in both pediatric and adult populations.